PD Dr. Agnes Bosch

Medizinische Fakultät Department of Medicine 4 – Nephrology and Hypertension

Hypertrophic remodelling of retinal arterioles in patients with congestive heart failure (2021) Jung S, Kolwelter J, Bosch A, Cífková R, Harazny JM, Ott C, Achenbach S, Schmieder R Journal article Dependency of flow-mediated vasodilatation from basal nitric oxide activity (2021) Kannenkeril D, Bosch A, Kolwelter J, Jung S, Striepe K, Ott C, Delles C, Schmieder R Journal article Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction (2021) Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, et al. Journal article Novel approaches to management of hypertension (2021) Bosch A, Schmieder R Journal article, Review article Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography (2020) Jung S, Bosch A, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder R Journal article Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes (2020) Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, et al. Journal article Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes (2019) Jung S, Bosch A, Kannenkeril D, Karg M, Striepe K, Bramlage P, Ott C, Schmieder R Conference contribution Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes (2019) Jung S, Ott C, Kannenkeril D, Bosch A, Karg M, Striepe K, Bramlage P, Schmieder R Conference contribution Disparate effects of the combined therapy of empagliflozin and linagliptin versus metformin and insulin glargine on renal haemodynamics in type 2 diabetes (2019) Ott C, Jung S, Kannenkeril D, Striepe K, Bosch A, Korn M, Bramlage P, Schmieder R Conference contribution IMPACT OF BLOOD PRESSURE AND AGEING ON RETINAL NEURODEGENERATION ASSESSED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY (2019) Jung S, Bosch A, Kohler N, Ott C, Kannenkeril D, Dienemann T, Harazny JM, et al. Conference contribution